Alan B. Sandler - 18 Nov 2024 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Role
Chief Medical Officer
Signature
/s/ Shelly PInto, by power of attorney
Issuer symbol
ALXO
Transactions as of
18 Nov 2024
Net transactions value
$0
Form type
4
Filing time
19 Nov 2024, 16:05:47 UTC
Previous filing
07 Aug 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALXO Employee Stock Option (right to buy) Award $0 +600,000 $0.000000 600,000 18 Nov 2024 Common Stock 600,000 $1.22 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth of the shares subject to the option vest on November 18, 2025 and 1/48th of the shares vest monthly thereafter.